Demand
← Earnings Calls
01
02
03
04 05 06
Tone
Capex
A1 A2 A3
LMT
FY2025 Q3
Raised
Lockheed Martin Corporation earnings call
Buzzberg read
Record backlog of $179 billion and strong bookings
Lockheed Martin reported strong Q3 2025 with record backlog of $179bn, raised full-year guidance, and highlighted significant awards across PAC-3, JASM, CH-53K, and F-35. Management expressed increased confidence in supply chain investments from key partners (L3Harris, Northrop, General Dynamics) to support missile production ramps, while noting continued scaling challenges on CH-53K. The company is also self-funding prototype developments in space-based interceptors and autonomous systems. Record backlog of $179bn driven by $30bn+ in multi-year awards (PAC-3, JASM, CH-53K) and $11bn F-35 Lot 18/19 def.
Buzzberg read Record backlog of $179 billion and strong bookings Lockheed Martin reported strong Q3 2025 with record backlog of $179bn, raised full-year guidance, and highlighted significant awards across PAC-3, JASM, CH-53K, and F-35. Management expressed increased confidence in supply chain investments from key partners (L3Harris, Northrop, General Dynamics) to support missile production ramps, while noting continued scaling challenges on CH-53K. The company is also self-funding prototype developments in space-based interceptors and autonomous systems. Record backlog of $179bn driven by $30bn+ in multi-year awards (PAC-3, JASM, CH-53K) and $11bn F-35 Lot 18/19 def. Read full analysisCollapse analysis
Lockheed Martin reported strong Q3 2025 with record backlog of $179bn, raised full-year guidance, and highlighted significant awards across PAC-3, JASM, CH-53K, and F-35. Management expressed increased confidence in supply chain investments from key partners (L3Harris, Northrop, General Dynamics) to support missile production ramps, while noting continued scaling challenges on CH-53K. The company is also self-funding prototype developments in space-based interceptors and autonomous systems. Record backlog of $179bn driven by $30bn+ in multi-year awards (PAC-3, JASM, CH-53K) and $11bn F-35 Lot 18/19 def.
- Raised FY2025 sales guide to $74.25-74.75bn, segment profit to $6.675-6.725bn, and EPS to $22.15-22.35.
- Supply chain confidence improving: Aerojet (L3Harris), Northrop Grumman, and General Dynamics investing in solid rocket motor capacity.
- F-35 Lot 19 transitions to firm fixed-price, providing margin opportunity; Block 4 development progressing with strong government collaboration.
Revenue$18.609BReported
EPS$6.95Reported
Gross margin12.04%Reported
Operating margin12.25%Reported
6 grounded callouts
What matters now
The highest-signal changes from the call.
Backlog
F-35 Lot 18/19 definitized at $11 billion
Golden Dome
Plan for on-orbit space-based interceptor demo by 2028
Show 3 more callouts
Supply
MFC capacity expansion supported by supplier investments
Guidance
RMS sales guidance cut $500M due to CH-53K ramp
Cash Flow
Pension pre-funding and cash deployment strategy
Reported period
Actuals
| Metric | Reported | Change |
|---|---|---|
| Revenue | $18.609B | Reported |
| EPS | $6.95 | Reported |
| Gross margin | 12.04% | Reported |
| Operating margin | 12.25% | Reported |
| Free cash flow | $3.347B | Reported |
| Capex | $0.381B | Reported |
Forward-looking
Forward guidance
| Metric | Period | Range | Midpoint | Status |
|---|---|---|---|---|
| EPS | FY2025 | $22.15–$22.35 | $22.25 | Raised |
| Free cash flow | FY2025 | $6.6B | $6.6B | Maintained |
| Operating margin | FY2025 | $6.675B–$6.725B | $6.7B | Raised |
| Revenue | FY2025 | $74.25B–$74.75B | $74.5B | Raised |
AI, capex & demand read
Management read
Upbeat
Management expressed strong confidence in record backlog, robust demand, and growth prospects, while acknowledging risks were being addressed.
Investment and capacity
Management noted that capital expenditures and internal R&D spending are expected to remain at roughly 2.5% of revenue, but could increase if demand ramps significantly, with more clarity in January. They highlighted that investments in production capacity, particularly for missiles and sensors, are being made to support Golden Dome and other growth opportunities.
all 4 named companies below
Companiesreturns since call
Suppliers
Suppliers
Jim Taklett
NOC is increasing investment in solid rocket motor capacity, directly benefiting from Lockheed's PAC-3 and other missile production ramps.
Evidence
“Northrop Grumman made a big commitment, again, to investment on the SRMs”
Suppliers
Jim Taklett
GD's JV with Lockheed will provide a third source for solid rocket motors, likely translating into new production revenue for GD's defense segment.
Evidence
“we've got a joint venture now with General Dynamics where we will have an ability to have a third supplier to bolster those two in the future”
Suppliers
Jim Taklett
RTX is a named subsystem supplier on F-35 Block 4, confirming ongoing collaboration but without new directional signal.
Evidence
“RTX is the distributed aperture system”
Suppliers
Jim Taklett
BAE is a key F-35 electronic warfare subsystem supplier; program momentum supports BAE's defense electronics revenue.
Evidence
“BAE is the EW system”
External signals
Supply-chain alpha · 3returns since call
Lockheed is self-funding a space-based interceptor prototype for on-orbit demonstration by 2028, signaling a shift to corporate-level IRAD for early technology insertion.
Evidence
“we are actually planning for a real on-orbit space-based interceptor demonstration by 2028”
F-35 Lot 19 transitions to true firm-fixed-price contract, enabling more margin upside vs. prior FPAF structure as production stabilizes after TR-3 challenges.
Evidence
“with Lot 19, we are transitioning to a true firm fixed price contract relative to the FPAF that we've seen previously”
CH-53K scaling is the primary driver of RMS guidance reduction, indicating production ramp issues that may affect Sikorsky's supply chain and subcontractors.
Evidence
“CH-53K is the largest driver as we work to scale production”
Methodology & coverage
Management-only analysis. All 4 validated company mentions are shown. Reported actuals and forward guidance are kept separate. Public evidence is limited to eight short attributed quotes. AI-generated analysis can be incomplete or wrong; verify important claims against the original source.